Screener
Pelthos Therapeutics PTHS Business Segments
| Q1 '26 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | ||
|---|---|---|---|---|---|---|
| Total Revenue by Business | ||||||
| Commercial operations | $10.67M— | $0— | $0— | $0— | $0— | |
| Research and Development operations | $241K— | $0— | $0— | $0— | $0— | |
| Total Revenue by Product | ||||||
| License and collaboration revenues | $241K— | $0— | $0— | $0— | $0— | |
| Net product revenues | $10.67M— | $0— | $0— | $0— | $0— |
FAQ
- How does Pelthos Therapeutics break its business down?
- Pelthos Therapeutics (PTHS) reports total revenue by business across 2 parts — Commercial operations and Research and Development operations. Each is extracted from the segment footnotes and tracked over time.
- Where does Pelthos Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Pelthos Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
